Establishing secure connection…Loading editor…Preparing document…

Healthcare Alcohol Study Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE ALCOHOL STUDY FORM

Study Identification

Investigator Name:

Study Title:

Study ID:    Date of Visit:

Patient Information

Date of Birth:    Gender: Male Female Non-binary Other:

Emergency Contact

Insurance Information

Medical History

Current tobacco use: Yes No    Current illicit drug use: Yes No

Alcohol Use Assessment

1. How often do you have a drink containing alcohol?
Never Monthly or less 2–4 times a month 2–3 times a week 4 or more times a week

2. How many standard drinks do you have on a typical day when you are drinking?

3. How often do you have six or more drinks on one occasion?
Never Less than monthly Monthly Weekly Daily or almost daily

4. In the past 12 months, have you felt you should cut down on your drinking? Yes No

5. In the past 12 months, have friends or family expressed concern about your drinking? Yes No

Date of last alcohol use:

Procedure and Consent

Description of study procedures: The study involves completion of alcohol use questionnaires, brief interview, and may include a breathalyzer test and collection of a small blood sample for biomarker analysis. Participation will take approximately two visits of up to one hour each and may include short telephone follow-up. Participation is voluntary.

Risks and discomforts: Risks include temporary discomfort from blood draw, transient lightheadedness, possible emotional distress discussing alcohol use, and minimal risk of loss of confidentiality. Reasonable precautions will be taken to protect privacy and data security.

Potential benefits: There may be no direct benefit to you. The study may contribute to improved clinical understanding and treatment of alcohol-related health issues.

Voluntary participation and withdrawal: You may refuse to participate or withdraw at any time without penalty or loss of benefits to which you are otherwise entitled. Withdrawal will not affect your medical care. Data already collected prior to withdrawal may be retained for study integrity unless you request otherwise in writing.

I consent to the following procedures (check all that apply):
Completion of questionnaires and interview
Breathalyzer test for recent alcohol use
Blood draw for biomarker analysis
Telephone follow-up contact

Privacy and HIPAA Authorization

Authorization: I authorize the study team to use and disclose my protected health information (PHI) necessary for the conduct of this research, including medical records related to alcohol use and laboratory results. Protected information will be limited to the minimum necessary to achieve the study objectives.

Confidentiality: Identifiers will be removed or replaced with a unique code for analysis. All study data will be stored in secure systems with access limited to authorized study personnel. Information that may identify you will not be used in publications or presentations without additional permission.

I authorize release of PHI for research purposes: Yes No

Authorization expiration date: . If left blank, authorization expires at the conclusion of the study.

Certifications and Acknowledgment

By signing below I certify that I have read and understood the information on this form, that my questions have been answered to my satisfaction, and that I freely consent to participate in this study. I understand the uses and limits of confidentiality and my right to withdraw at any time. I acknowledge that I have been given the opportunity to discuss risks, benefits, and alternatives with study personnel.

Patient Name:

Signature:

Date:

If signed by a legally authorized representative, relationship to patient:

Representative printed name (if applicable):

Enter text✕

What the Healthcare Alcohol Study Form Is

The Healthcare Alcohol Study Form is a standardized clinical research and screening document used to record a participant's alcohol use history, screening results, informed consent for study participation, and any study-specific instructions. It typically combines demographic identifiers, validated screening items (for example AUDIT-C or similar instruments), consent language, and signature blocks. In clinical settings the form supports study enrollment, risk assessment, and continuity of care while ensuring that responses and signatures are recorded in a verifiable, auditable format suitable for regulatory review and data analysis.

Why this Form Matters for Clinical Research and Care

Using a consistent Healthcare Alcohol Study Form ensures accurate baseline screening, documents informed consent, and creates an auditable record that supports patient safety and regulatory compliance, including HIPAA protections for personal health information.

Why this Form Matters for Clinical Research and Care

Who Typically Completes and Manages This Form

Multiple roles interact with the Healthcare Alcohol Study Form during recruitment, enrollment, and follow-up.

  • Study coordinators and research nurses who administer screening tools and collect consent at intake.
  • Principal investigators and clinicians who use results for risk assessment and treatment planning.
  • IRB administrators and data managers who verify consent, store records, and report compliance.

Each participant entry should link to a study ID and be stored under the project retention schedule to meet regulatory and sponsor requirements.

Primary Signers and Authorized Representatives

Primary Signer — Participant

The adult participant signs to confirm informed consent and truthfulness of responses; the signature documents intent to participate and authorizes use of de-identified data. If the participant is a minor or unable to consent, an authorized guardian signs instead.

Authorized Representative — Study Staff

A study coordinator or delegated clinician may countersign to verify that the consent process followed IRB-approved procedures and that screening items were administered correctly; this record documents chain-of-custody for the consent.

Essential Sections to Include in the Form

A professional Healthcare Alcohol Study Form groups data into clear sections so reviewers can find consent, screening results, and signature proofs without ambiguity.

Participant Data

Full legal name, date of birth, contact details, and study ID to uniquely identify the record during follow-up and audit.

Screening Items

Validated questions such as AUDIT-C items scored per protocol; include response options, scoring instructions, and a space for the total score.

Informed Consent

Clear consent language describing purpose, procedures, risks, benefits, data use, voluntary participation, and withdrawal rights per IRB-approved text.

Clinical Notes

A brief clinician or coordinator notes field to record contextual observations, referral recommendations, or actions taken after screening.

Signature Block

Designated signature and date fields for participant and witness or study staff, plus a recorded method of signing (electronic, witnessed paper, RON).

Data Handling

Checkboxes for PHI sharing consent, de-identification intent, and storage location along with record retention shorthand.

Data and Security Items to Track on the Form

PHI Flag: Mark whether responses contain protected health information
HIPAA BAA: Note if a business associate agreement is in place
Encryption: State data-at-rest and in-transit protections
Access Controls: Record role-based access for study staff
Audit Trail: Capture timestamps, IP, and signer attribution
Retention: Specify retention policy and legal basis

Step-by-Step: Completing the Healthcare Alcohol Study Form

Follow these steps in order to collect valid screening data and document informed consent in a compliant, auditable way.

  • 01
    Prepare the form: Use the IRB‑approved version and pre-fill study ID information
  • 02
    Explain consent: Read or present the consent script before any screening items
  • 03
    Record responses: Enter screening answers exactly as provided and calculate scores per protocol
  • 04
    Capture signature: Obtain participant signature and staff countersignature with audit metadata

Configuring an Online Workflow for This Form

Set up a digital workflow to ensure consent, screening, and secure storage are consistently applied across participants.

Field Configuration
Authentication Email link or SMS code
Consent Disclosure Present ESIGN consumer disclosure where required
HIPAA BAA Enable only with a signed BAA
Storage Format PDF/A with embedded audit trail

Technical Considerations for eSubmission

Choose a platform that supports HIPAA protections, audit trails, and the file formats your sponsor requires.

  • File formats: PDF, DOCX, and PDF/A supported
  • Integrations: Connectors for EHR and cloud storage
  • Accessibility: WCAG Level AA compatibility available

Confirm the platform meets your IRB and sponsor technical specifications, and document any third‑party contracts such as BAAs.

Timing Considerations and Reporting Expectations

Key timing items affect enrollment validity, IRB reporting, and record retention—track these dates closely.

Consent Timing:

Obtain consent before any study procedures or data collection

Data Entry Window:

Enter screening results into the study database within 72 hours when possible

Adverse Event Reporting:

Report per IRB and sponsor timelines, as specified in study documents

Continuing Review:

Submit annual or IRB-required continuing review materials on schedule

Record Retention:

Follow HIPAA and sponsor retention policies, often six years

Common Pitfalls to Avoid During Preparation

  • Leaving required fields blank or using inconsistent study IDs, which forces re-contact and delays enrollment.
  • Collecting signatures without documenting the authentication method or without the ESIGN consumer disclosure when required.
  • Using informal scoring or manual totals without cross-checks, increasing error risk in eligibility determinations.
  • Storing signed PDFs in unsecured folders or sending them by unsecured email, exposing PHI and violating policy.

Consequences of Incorrect or Incomplete Forms

HIPAA Violations: Civil or criminal liability may follow
IRB Noncompliance: Study suspension or corrective action
Invalid Consent: Data may be unusable for research
Data Breach: Notification duties and remediation
Regulatory Audit: Increased scrutiny and documentation requests
Legal Liability: Potential civil claims from subjects

Real-World Examples of Use

Clinical teams and research organizations use similar forms to streamline enrollment and maintain auditable consent records.

Fertility Centers of Illinois

The clinic adopted a digital consent workflow to reduce paper handling and speed turnarounds.

  • Staff reported faster enrollment coordination.
  • The organization preserved signed consents with audit trails and maintained HIPAA-compliant storage per sponsor demands, improving traceability during audits.

Optica Ventures LLC

A community clinic used a standardized alcohol screen for primary care patients.

  • Coordinators captured scores electronically at intake.
  • Electronic capture allowed consistent follow-up scheduling, easier referrals, and unified storage for program evaluation.

eSignature Vendor Pricing Snapshot for Study Workflows

Typical vendor pricing and feature availability for secure eSignature solutions; signNow appears first for comparison purposes.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Frequently Asked Questions

Answers to common questions about legality, signatures, HIPAA, and storage for the Healthcare Alcohol Study Form.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users